CBHD.STU COLOPLAST -B- (CBHD.SG)
- Market cap
- -
- P/E
- 39.0x
- P/B
- 6.79x
- ROE
- 7.3%
- Dividend yield
- 12.11%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is CBHD.STU undervalued?
Graham numberThe Graham number of COLOPLAST -B- (CBHD.SG) cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
COLOPLAST -B- (CBHD.SG) fundamental analysis
No fundamental analysis for COLOPLAST -B- (CBHD.SG) yet.
COLOPLAST -B- (CBHD.SG) stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
COLOPLAST -B- (CBHD.SG) financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
COLOPLAST -B- (CBHD.SG) annual financial statements (DKK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 14.7B | 15.5B | 16.4B | 17.9B | 18.5B | 19.4B | 22.6B | 24.5B | 27.0B | 28.9B |
| Gross Profit | 10.0B | 10.6B | 11.1B | 12.2B | 12.6B | 13.3B | 15.5B | 16.3B | 18.3B | 19.3B |
| Operating Income | 4.85B | 5.02B | 5.09B | 5.56B | 5.85B | 6.36B | 6.91B | 6.85B | 7.29B | 7.50B |
| EBITDA | - | 5.57B | 5.65B | 5.69B | 6.35B | 7.05B | 7.23B | 7.73B | 8.48B | 9.47B |
| Net Income | 3.14B | 3.80B | 3.85B | 3.87B | 4.20B | 4.83B | 4.71B | 4.78B | 5.05B | 982M |
| EPS | - | 18 | 18 | 18 | 20 | 23 | 22 | 21 | 22 | 4.36 |
| Balance Sheet | ||||||||||
| Total Assets | 11.0B | 12.1B | 11.8B | 12.7B | 13.5B | 15.8B | 37.4B | 48.2B | 48.1B | 46.9B |
| Total Liabilities | 5.94B | 6.10B | 5.35B | 5.82B | 6.09B | 7.67B | 29.2B | 30.9B | 30.1B | 33.6B |
| Shareholders' Equity | 5.07B | 5.95B | 6.42B | 6.91B | 7.41B | 8.17B | 8.29B | 17.3B | 17.9B | 13.4B |
| Cash & Short-term Investments | 546M | 314M | 297M | 356M | 323M | 448M | 414M | 911M | 788M | 817M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 3.03B | 3.25B | 4.36B | 4.36B | 4.76B | 5.29B | 5.10B | 4.23B | 2.77B | 6.35B |
| Capital Expenditure | 649M | 685M | 669M | 636M | 931M | 1.97B | 1.14B | 1.24B | 1.35B | 1.49B |
| Free Cash Flow | - | 2.57B | 3.69B | 3.72B | 3.83B | 3.32B | 3.96B | 2.99B | 1.42B | 4.86B |
| Ratios | ||||||||||
| ROE | 62.0% | 63.8% | 59.9% | 56.0% | 56.7% | 59.1% | 56.8% | 27.6% | 28.2% | 7.3% |
| ROA | 28.6% | 31.5% | 32.7% | 30.4% | 31.1% | 30.5% | 12.6% | 9.9% | 10.5% | 2.1% |
| Net Profit Margin | 21.4% | 24.5% | 23.4% | 21.6% | 22.6% | 24.8% | 20.8% | 19.5% | 18.7% | 3.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
COLOPLAST -B- (CBHD.SG) dividends
- Dividend yield
- 12.11%
- Forward dividend
- -
- Payout ratio
- 93.4%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2024 | DKK 4.72B | 21 | 93.4% |
| 2023 | DKK 4.25B | 19 | 88.8% |
| 2022 | DKK 4.04B | 19 | 85.9% |
| 2021 | DKK 3.83B | 18 | 79.4% |
| 2020 | DKK 3.61B | 17 | 86.1% |
| 2019 | DKK 3.40B | 16 | 87.7% |
| 2018 | DKK 3.29B | 15 | 85.5% |
| 2017 | DKK 2.86B | 13 | 75.4% |
| 2016 | DKK 2.65B | - | 84.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 5:1 on Dec 19, 2012.
Who owns COLOPLAST -B- (CBHD.SG)
Ownership data of COLOPLAST -B- (CBHD.SG) is not available yet.
COLOPLAST -B- (CBHD.SG) company profile
- Company name
- COLOPLAST -B- (CBHD.SG)
- Ticker
- CBHD.STU
- ISIN
- DK0060448595
- Exchange
- Stuttgart Exchange
- Sector
- Other
- Industry
- Metals & Mining
- Fiscal year end
- September
- Address
- Website
- -
About COLOPLAST -B- (CBHD.SG)
There is no Profile data available for CBHD.SG.